Tuesday, March 8, 2016

International food & pharma automation event.

ISA’s 2016 FPID Symposium showcases two acclaimed keynote speakers, an extensive technical program, and two valuable training courses

Conference sessions
to include:

Cybersecurity
Sustainable processing
Data integrity
Alarm management
Industrial Internet of Things
Usage of cloud for automation
Instrumentation: calibration, wireless
Batch management & MES
ISA standards
Process optimization
Serialization/ Track and Trace
OEE, PAT, GAMP
Energy/ waste management
Process control
Paperless automation
Manufacturing regulations
Leading innovators and other professionals involved in automating food, beverage and pharmaceutical processing—and two highly distinguished keynote speakers—will highlight the 2016 ISA Food and Pharmaceutical Industries (FPID) Symposium, 14-15 March in beautiful Cork, Ireland.

This dynamic event will explore how automation can help address critical challenges—relating to regulatory requirements, manufacturing costs, security threats and other concerns—within the food and pharmaceutical sectors. Special attention will examine the role of automation technology and innovation in meeting longer-term global dynamics and demands.

Conference sessions, led by the world’s leading experts, will cover a wide range of critical issues and topics (see box on right).

Learn about the latest products and services
An exhibit showcase will feature the latest product and service information at engaging vendor and supplier exhibits. Sponsorships and exhibit spaces are still available, providing an opportunity to directly connect with key decision makers.

Daily networking luncheons and receptions will set the stage for mingling, meeting new people and reconnecting with old friends.

Paul McKenzie is the Senior Vice President for Global Biologics Manufacturing & Technical Services at Biogen, a position he assumed earlier this year.
As Senior Vice President for Global Biologics Manufacturing & Technical Operations, McKenzie is responsible for the manufacturing, engineering, and manufacturing sciences operations in Denmark, Switzerland, Massachusetts and North Carolina. These large-scale biopharmaceutical facilities cover drug substance and finished goods with a focus on next-generation automation and manufacturing. McKenzie oversees the production of life-changing medicines to patients around the world with five commercial products available, including AvonexTM, TysabriTM, ElocatateTM, AlprolixTM and PeglidryTM. He is a member of the Pharmaceutical Operations & Technology Leadership Team where he brings a strong focus to ensuring clinical supply of product and providing patient convenience.
Prior to his current role, McKenzie was the Vice President of Johnson & Johnson Medical Devices, Ethicon Research & Development (R&D). As a member of the Ethicon Global Management Board and the Johnson & Johnson Medical Devices R&D Leadership Team, he was responsible for R&D’s global strategy, portfolio prioritization and execution, resource strategy and development, and advancement of R&D talent.

McKenzie holds a bachelor of science degree in chemical engineering from the University of Pennsylvania and a doctorate degree in chemical engineering from Carnegie Mellon University. He has served on numerous professional and academic boards, and is currently a member of the Board of Trustees on the Illinois Institute of Technology and the Society for Biological Engineering.


Peter Martin
Peter Martin is widely recognized as one of the most influential professionals and experts in automation and control. He has held a range of executive and technical positions in engineering, product and strategic planning, marketing and training throughout his career. He served as Vice President of Invensys Operations Management for 37 years.
Dr. Martin holds multiple patents, including patents for dynamic performance measures, real-time activity-based costing, closed-loop business control, and asset and resource modeling. He has published numerous articles and technical papers, and has authored or co-authored six books. An ISA Fellow, Dr. Martin is a recipient of the ISA Life Achievement Award, and has been named as one of the 50 most influential innovators of all time in instrumentation and controls.

He has earned numerous academic degrees, including: a bachelor of arts degree and master of science degree in mathematics; a master of arts degree in administration and management, a master of arts and a doctorate degree in biblical studies; and a doctorate degree in industrial engineering.

Two outstanding keynote speakers
Two widely recognized leaders in automation—   Paul McKenzie, Ph.D., Senior Vice President of Global Biologics Manufacturing & Technical Services at Biogen;; and Peter Martin, Ph.D., Vice President and Fellow at Schneider Electric Company—will deliver keynote addresses during the event. Below are the presentation titles and abstracts as well as summary biographies of these two highly remarkable speakers.

“Using Data to Optimize the Product Life Cycle”
Speaker: Marc Hooybergs (see box on right)

Pharmaceutical product development presents challenges with respect to the rigor in both scientific and ultimately engineering knowledge around the process to ensure consistent product quality. The industry is under increasing demand to reduce costs of development and ultimately production of such medicinal products that ultimately is forcing organizations to recalibrate their knowledge management strategies. Knowledge management is a business problem first and foremost but can be accelerated with the underlying information technologies platform selections. As such, this presentation will focus on the adaptation of ISA-88/95 and underlying infrastructure for the semantic definition and capture of knowledge across a product development lifecycle leveraging open source.

“Innovation and a Future Perspective on Automation and Control”
Speaker: Dr Peter Martin

Industrial automation is a field in which continual and impactful innovations have occurred over the last century. Today there are a number of key initiatives and technologies in industrial automation, such as the Industrial Internet of Things (IIoT), Cyber-Physical Systems (CPS), Industrie 4.0, cloud computing, and big data analytics that, taken as a whole, may be indicative of a period of breakthrough innovation that has not been seen since the introduction of the computer as a delivery vehicle for control. This presentation will investigate the different levels of innovation, why industrial automation and control may be at an inflection point leading to inspirational innovation and what this might in terms of performance improvements for food and pharmaceutical companies.

Training Courses
Attendees will add value to their event experience by taking an on-location ISA training course. Two high-value ISA courses are offered:

To register, or to gain more information on-line here at ISA’s 2016 Food and Pharmaceutical Industries Symposium.


#FPID16 #PAuto #Pharma @IrelandISA

No comments:

Post a Comment